According to Meridian Bioscience's latest financial reports the company's current revenue (TTM) is $0.33 B. In 2021 the company made a revenue of $0.31 B an increase over the years 2020 revenue that were of $0.29 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $0.33 B | 6.29% |
2021 | $0.31 B | 4.73% |
2020 | $0.29 B | 51.89% |
2019 | $0.19 B | -7.43% |
2018 | $0.21 B | 3.16% |
2017 | $0.20 B | 5.37% |
2016 | $0.19 B | 0.9% |
2015 | $0.19 B | 1% |
2014 | $0.19 B | 2.08% |
2013 | $0.18 B | 5.32% |
2012 | $0.17 B | 9.77% |
2011 | $0.16 B | 18.08% |
2010 | $0.13 B | -11.91% |
2009 | $0.15 B | 11.67% |
2008 | $0.14 B | 9.36% |
2007 | $0.12 B | 14.14% |
2006 | $0.11 B | 13.32% |
2005 | $99.03 M | 23.35% |
2004 | $80.28 M | 18.19% |
2003 | $67.92 M | 10.18% |
2002 | $61.65 M | 12.45% |
2001 | $54.82 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $42.85 B | 12,769.27% | ๐บ๐ธ USA |
Becton Dickinson BDX | $19.49 B | 5,753.14% | ๐บ๐ธ USA |
Hologic HOLX | $3.96 B | 1,091.92% | ๐บ๐ธ USA |
QuidelOrtho QDEL | $2.99 B | 800.19% | ๐บ๐ธ USA |